KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
$ 24.50
0.00%
(0.00) 1D
10-р сарын 1, 10:21:43 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KSPHF...
Mkt. cap
172.44Т
Avg. vol.
20.00
Volume
0.00
52-wk high
$ 31.90
52-wk low
$ 24.50
Beta
13.94
Shares outstanding
46.54 сая
No. of employees
2 мян
Mkt. cap
172.44Т
Avg. vol.
20.00
Volume
0.00
52-wk high
$ 31.90
52-wk low
$ 24.50
Beta
13.94
Shares outstanding
46.54 сая
No. of employees
2 мян
News stories
From web sources and news partners
Deadline
·
1 цагийн өмнө
Skydance Shares Fall In New York Stock Exchange Debut As Investors Fret Over Debt
Stock Titan
·
1 цагийн өмнө
A Nasdaq notice gives IB Acquisition (Nasdaq: IBAC) 45 days to submit a compliance plan.
Bloomberg.com
·
18 минутын өмнө
Record Run for US Stocks to Set Tone for Asia: Markets Wrap
Investor's Business Daily
·
1 цагийн өмнө
Dow Jones Futures: S&P 500 Hits High As Astera, GE Vernova, Arista Lead 6 AI Stock Buys
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1.79 мян
Founded1946 оны 8-р сарын 9
HeadquartersMatsumoto, Nagano, Япон
SectorPharmaceutical industry
Websitekissei.co.jp